Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamy Patrick
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer White William Richard
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gangloff Scott A.
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamy Patrick
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer White William Richard
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan
Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona
Akero Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.2%)
Akero Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(5.5%)